Cargando…
Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722575/ https://www.ncbi.nlm.nih.gov/pubmed/36479545 http://dx.doi.org/10.1097/HS9.0000000000000813 |
| _version_ | 1784843992803835904 |
|---|---|
| author | Delforge, Michel Vekemans, Marie-Christiane Depaus, Julien Meuleman, Nathalie Van de Velde, Ann Vande Broek, Isabelle Vandervennet, Sophie Van Hoorenbeeck, Sandra Moorkens, Evelien Strens, Danielle Diels, Joris Ghilotti, Francesca Haefliger, Benjamin Dalhuisen, Sander Deraedt, William Anguille, Sébastien |
| author_facet | Delforge, Michel Vekemans, Marie-Christiane Depaus, Julien Meuleman, Nathalie Van de Velde, Ann Vande Broek, Isabelle Vandervennet, Sophie Van Hoorenbeeck, Sandra Moorkens, Evelien Strens, Danielle Diels, Joris Ghilotti, Francesca Haefliger, Benjamin Dalhuisen, Sander Deraedt, William Anguille, Sébastien |
| author_sort | Delforge, Michel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9722575 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97225752022-12-06 Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice Delforge, Michel Vekemans, Marie-Christiane Depaus, Julien Meuleman, Nathalie Van de Velde, Ann Vande Broek, Isabelle Vandervennet, Sophie Van Hoorenbeeck, Sandra Moorkens, Evelien Strens, Danielle Diels, Joris Ghilotti, Francesca Haefliger, Benjamin Dalhuisen, Sander Deraedt, William Anguille, Sébastien Hemasphere Letter Lippincott Williams & Wilkins 2022-11-29 /pmc/articles/PMC9722575/ /pubmed/36479545 http://dx.doi.org/10.1097/HS9.0000000000000813 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter Delforge, Michel Vekemans, Marie-Christiane Depaus, Julien Meuleman, Nathalie Van de Velde, Ann Vande Broek, Isabelle Vandervennet, Sophie Van Hoorenbeeck, Sandra Moorkens, Evelien Strens, Danielle Diels, Joris Ghilotti, Francesca Haefliger, Benjamin Dalhuisen, Sander Deraedt, William Anguille, Sébastien Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice |
| title | Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice |
| title_full | Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice |
| title_fullStr | Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice |
| title_full_unstemmed | Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice |
| title_short | Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice |
| title_sort | ciltacabtagene autoleucel for patients with triple-class exposed multiple myeloma: adjusted comparison of cartitude-1 patient outcomes versus real-world clinical practice |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722575/ https://www.ncbi.nlm.nih.gov/pubmed/36479545 http://dx.doi.org/10.1097/HS9.0000000000000813 |
| work_keys_str_mv | AT delforgemichel ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT vekemansmariechristiane ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT depausjulien ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT meulemannathalie ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT vandeveldeann ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT vandebroekisabelle ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT vandervennetsophie ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT vanhoorenbeecksandra ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT moorkensevelien ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT strensdanielle ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT dielsjoris ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT ghilottifrancesca ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT haefligerbenjamin ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT dalhuisensander ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT deraedtwilliam ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice AT anguillesebastien ciltacabtageneautoleucelforpatientswithtripleclassexposedmultiplemyelomaadjustedcomparisonofcartitude1patientoutcomesversusrealworldclinicalpractice |